DICHIARA, MARIA
 Distribuzione geografica
Continente #
AS - Asia 1.469
EU - Europa 960
NA - Nord America 955
SA - Sud America 409
AF - Africa 29
Totale 3.822
Nazione #
US - Stati Uniti d'America 921
SG - Singapore 493
RU - Federazione Russa 460
CN - Cina 388
BR - Brasile 339
IT - Italia 282
KR - Corea 156
VN - Vietnam 142
HK - Hong Kong 127
IN - India 58
GB - Regno Unito 32
AR - Argentina 28
DE - Germania 25
IE - Irlanda 21
NL - Olanda 21
AT - Austria 19
BD - Bangladesh 18
FI - Finlandia 18
MX - Messico 18
ID - Indonesia 14
CA - Canada 13
IR - Iran 12
ES - Italia 11
ZA - Sudafrica 11
UA - Ucraina 10
EC - Ecuador 9
PL - Polonia 9
FR - Francia 8
IQ - Iraq 7
JP - Giappone 7
TR - Turchia 7
CO - Colombia 6
PE - Perù 6
PY - Paraguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
PK - Pakistan 5
AL - Albania 4
AZ - Azerbaigian 4
BE - Belgio 4
CH - Svizzera 4
CI - Costa d'Avorio 4
CL - Cile 4
CZ - Repubblica Ceca 4
KE - Kenya 4
KG - Kirghizistan 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
UZ - Uzbekistan 4
LV - Lettonia 3
SE - Svezia 3
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
MK - Macedonia 2
RS - Serbia 2
SA - Arabia Saudita 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SN - Senegal 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 3.822
Città #
Dallas 401
Singapore 280
Hefei 187
Seoul 153
Moscow 132
Hong Kong 125
Santa Clara 106
Beijing 80
Ho Chi Minh City 53
Ashburn 48
Siena 48
Milan 43
Los Angeles 42
Bengaluru 39
Hanoi 29
Florence 26
Chicago 25
São Paulo 25
Rome 24
Dublin 21
Buffalo 17
Redondo Beach 16
Nuremberg 14
Catania 13
Vienna 13
Lappeenranta 12
Tehran 11
Rio de Janeiro 10
Salt Lake City 9
Belo Horizonte 8
Lucca 8
Mexico City 8
New York 8
Turin 8
The Dalles 7
Warsaw 7
Asunción 6
Council Bluffs 6
Haiphong 6
Montreal 6
Phoenix 6
Tokyo 6
Bologna 5
Chennai 5
Curitiba 5
Da Nang 5
Denver 5
Johannesburg 5
Lima 5
Manaus 5
Phủ Lý 5
Piscataway 5
Poplar 5
Quito 5
Salvador 5
Santo André 5
Abidjan 4
Amsterdam 4
Atlanta 4
Baghdad 4
Baku 4
Bishkek 4
Boardman 4
Bogotá 4
Brescia 4
Brooklyn 4
Caivano 4
Campo Grande 4
Cape Town 4
Columbus 4
Dhaka 4
Draper 4
Helsinki 4
Hortolândia 4
Hải Dương 4
Islamabad 4
Messina 4
Nairobi 4
Orem 4
Pelotas 4
Porto Alegre 4
Pouso Alegre 4
Tashkent 4
Ubá 4
Volta Redonda 4
Ankara 3
Bari 3
Bergamo 3
Biên Hòa 3
Brasília 3
Campinas 3
Caracas 3
Genoa 3
Hillsboro 3
Houston 3
Irpin 3
Joinville 3
João Pessoa 3
Juiz de Fora 3
Kyiv 3
Totale 2.323
Nome #
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients 301
Biostimulants for Sustainable Food Production: Effects of Wood Distillate to Fortify Chickpea Flour for Development of Functional Bakery Products 172
Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3 124
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: design, synthesis, and pharmacological evaluation 120
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 115
Discovery of p-Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox Virus 109
Novel N-normetazocine derivatives with opioid Agonist/Sigma-1 receptor antagonist profile as potential analgesics in inflammatory pain 108
Cytotoxicity profiles and neuroprotective properties of the novel ifenprodil analogues as sigma ligands 102
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 97
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] derivatives as potent and selective sigma receptor ligands: stereochemistry and pharmacological properties 97
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors 95
Unlocking the potential of biostimulants in sustainable agriculture: Effect of wood distillate on the nutritional profiling of apples 90
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 88
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain 87
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds 86
Novel N-Substituted benzomorphan-based compounds: from MOR-agonist/DOR-antagonist to biased/unbiased MOR agonists 85
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity 84
Nitric oxide photo-donor hybrids of ciprofloxacin and norfloxacin: a shift in activity from antimicrobial to anticancer agents 84
Designing drugs optimized for both blood–brain barrier permeation and intra-cerebral partition 83
Synthesis, computational insights, and evaluation of novel sigma receptors ligands 83
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity 83
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 82
Correction to “Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents” 81
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 80
Discovery, affinity maturation and multimerization of small molecule ligands against human tyrosinase and tyrosinase-related protein 1 80
Structural and molecular insight into Piperazine and Piperidine derivatives as Histamine H3 and Sigma-1 receptor antagonists with promising antinociceptive properties 79
Exploiting the power of stereochemistry in drug action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as potent Sigma-1 receptor antagonist 76
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 74
Tuning properties for blood-brain barrier permeation: a statistics-based analysis 73
Structure–Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis 72
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 71
H2S releasing molecules in pharmaceutical development 68
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches 68
Sigma-2 receptor ligands QSAR model dataset 66
Sigma receptor ligands carrying a nitric oxide donor nitrate moiety: synthesis, In silico, and biological evaluation 64
Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5ʹ-monophosphate glycosidase 62
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 62
New Insights into the Opioid Analgesic Profile of cis-(−)-N-Normetazocine-derived Ligands 59
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 59
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 59
Repurposing of human kinase inhibitors in neglected protozoan diseases 57
Open Source Antibiotics: Simple Diarylimidazoles Are Potent against Methicillin-Resistant Staphylococcus aureus 54
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: preliminary studies as a potential multifunctional agent against uveal melanoma 54
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 42
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 38
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 37
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 35
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors 34
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 32
Totale 4.011
Categoria #
all - tutte 11.259
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.259


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202363 0 0 0 0 0 0 0 0 0 0 62 1
2023/2024159 1 0 0 5 0 3 18 2 5 0 18 107
2024/20251.403 39 27 130 45 138 120 39 61 191 79 95 439
2025/20262.386 255 511 510 582 506 22 0 0 0 0 0 0
Totale 4.011